Lagis Enterprise Co., Ltd. (TPEX:6730)

Market Cap	1.42B +17.7%
Revenue (ttm)	487.65M +7.3%
Net Income	69.27M +1.5%
EPS	2.11 +0.5%
Shares Out	36.30M
PE Ratio	18.48
Forward PE	n/a
Dividend	1.50 (3.85%)
Ex-Dividend Date	Jul 17, 2025

Volume	4,300
Average Volume	40,614
Open	38.50
Previous Close	39.00
Day's Range	38.50 - 39.00
52-Week Range	34.50 - 52.20
Beta	0.20
RSI	71.70
Earnings Date	Apr 24, 2026

About Lagis Enterprise

Lagis Enterprise Co., Ltd. engages in the manufacturing, processing, and sale of surgical instruments, equipment, and related medical devices Taiwan and China. Its products include trocars, include optical tip trocar, dilating tip trocar, shielded bladed tip trocar, blunt tip trocar, TRE trocar system, balloon trocar; single port surgery devices, include advanced single port device, single port kit for TAMIS, and advanced single port device for vNOTES; path cap and shield wound reactors; energy bipolar forceps; suction irrigation systems and ir...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6730

Financial Performance

In 2025, Lagis Enterprise's revenue was 487.65 million, an increase of 7.33% compared to the previous year's 454.36 million. Earnings were 69.27 million, an increase of 1.51%.